FDA

FDA’s Vaccine Regulator Returns After Sudden Resignation

Dr. Vinay Prasad has been reinstated as director of the FDA’s Center for Biologics Evaluation and Research after stepping down.

FDA to Boost Domestic Pharmaceutical Production

The Food and Drug Administration (FDA) unveiled a new plan to boost the nation's domestic pharmaceutical supply.

Trump Voters Demand FDA Crackdown on Foreign Drug Threat

A new poll shows 92 percent of Trump voters want the Food and Drug Administration (FDA) to increase enforcement to protect Americans from unsafe prescription drugs, especially those imported from foreign manufacturers. The survey, conducted by Fabrizio Ward for Rx Border Defense, highlights overwhelming support among conservatives for stronger pharmaceutical oversight, American drug manufacturing, and secure borders.

Major Food Association Praised for Removing Dyes

The Consumer Brands Association launched an effort to Make America Healthy Again, committing to end the manufacturing of products with certified Food, Drug & Cosmetic (FD&C) colors by the end of 2027.

MAHA Win: FDA Approves New Natural Food Color

The Food and Drug Administration (FDA) announced that it has approved a petition to use gardenia (genipin) blue as a food dye.

FDA Approves New COVID Jab for Children

The FDA approved a new Moderna COVID-19 vaccine aimed at children aged 6 months to 11 years old. The vaccine was previously available under an Emergency Use Authorization (EUA).

FDA Pauses Trials Involving ‘Hostile Countries’

The U.S. Food and Drug Administration (FDA) announced a review of clinical trials involving "hostile countries," declaring that projects involving Americans' living cells are paused.

FDA Permits Lab-Grown Salmon

The U.S. Food and Drug Administration (FDA) has "no questions at this time" about a company's lab-grown salmon.

FDA Commissioner to Review Abortion Pill

FDA Commissioner Marty Makary confirmed that he will review the safety of the abortion drug mifepristone after a study revealed troubling adverse health outcomes exceeding the risks reported on its label.

FDA Launches AI Tool to Streamline Efficiency

The Food and Drug Administration launched a new tool intended to increase agency efficiency and streamline its processes.

Latest news

- Advertisement -spot_img